313 related articles for article (PubMed ID: 27503805)
1. Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.
Rutherford E; Talle MA; Mangion K; Bell E; Rauhalammi SM; Roditi G; McComb C; Radjenovic A; Welsh P; Woodward R; Struthers AD; Jardine AG; Patel RK; Berry C; Mark PB
Kidney Int; 2016 Oct; 90(4):845-52. PubMed ID: 27503805
[TBL] [Abstract][Full Text] [Related]
2. Novel cardiac nuclear magnetic resonance method for noninvasive assessment of myocardial fibrosis in hemodialysis patients.
Graham-Brown MP; March DS; Churchward DR; Stensel DJ; Singh A; Arnold R; Burton JO; McCann GP
Kidney Int; 2016 Oct; 90(4):835-44. PubMed ID: 27633869
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
[TBL] [Abstract][Full Text] [Related]
4. Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients.
Graham-Brown MP; Rutherford E; Levelt E; March DS; Churchward DR; Stensel DJ; McComb C; Mangion K; Cockburn S; Berry C; Moon JC; Mark PB; Burton JO; McCann GP
J Cardiovasc Magn Reson; 2017 Feb; 19(1):21. PubMed ID: 28238284
[TBL] [Abstract][Full Text] [Related]
5. Defining myocardial fibrosis in haemodialysis patients with non-contrast cardiac magnetic resonance.
Graham-Brown MP; Singh AS; Gulsin GS; Levelt E; Arnold JA; Stensel DJ; Burton JO; McCann GP
BMC Cardiovasc Disord; 2018 Jul; 18(1):145. PubMed ID: 30005636
[TBL] [Abstract][Full Text] [Related]
6. The association of secondary hyperparathyroidism and myocardial damages in hemodialysis end-stage renal disease patients: assessed by cardiovascular magnetic resonance native T1 mapping.
Xu H; Peng W; Yang Z; Zhang Y; Xia C; Li Z; Xu R; Guo Y
J Cardiovasc Magn Reson; 2021 Mar; 23(1):23. PubMed ID: 33691727
[TBL] [Abstract][Full Text] [Related]
7. Associations of B-type natriuretic peptide (BNP) and dialysis vintage with CMRI-derived cardiac indices in stable hemodialysis patients with a preserved left ventricular ejection fraction.
Han X; He F; Cao Y; Li Y; Gu J; Shi H
Int J Cardiovasc Imaging; 2020 Nov; 36(11):2265-2278. PubMed ID: 32686028
[TBL] [Abstract][Full Text] [Related]
8. A cardiac magnetic resonance imaging study of long-term and incident hemodialysis patients.
Thompson RB; Raggi P; Wiebe N; Ugander M; Nickander J; Klarenbach SW; Thompson S; Tonelli M;
J Nephrol; 2019 Aug; 32(4):615-626. PubMed ID: 30778918
[TBL] [Abstract][Full Text] [Related]
9. Defining Myocardial Abnormalities Across the Stages of Chronic Kidney Disease: A Cardiac Magnetic Resonance Imaging Study.
Hayer MK; Radhakrishnan A; Price AM; Liu B; Baig S; Weston CJ; Biasiolli L; Ferro CJ; Townend JN; Steeds RP; Edwards NC;
JACC Cardiovasc Imaging; 2020 Nov; 13(11):2357-2367. PubMed ID: 32682713
[TBL] [Abstract][Full Text] [Related]
10. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
[TBL] [Abstract][Full Text] [Related]
11. Acute impact of an endurance race on cardiac function and biomarkers of myocardial injury in triathletes with and without myocardial fibrosis.
Tahir E; Scherz B; Starekova J; Muellerleile K; Fischer R; Schoennagel B; Warncke M; Stehning C; Cavus E; Bohnen S; Radunski UK; Blankenberg S; Simon P; Pressler A; Adam G; Patten M; Lund GK
Eur J Prev Cardiol; 2020 Jan; 27(1):94-104. PubMed ID: 31242053
[TBL] [Abstract][Full Text] [Related]
12. Correlation between right ventricular T
Jellis CL; Yingchoncharoen T; Gai N; Kusunose K; Popović ZB; Flamm S; Kwon D
Int J Cardiovasc Imaging; 2018 Jan; 34(1):55-65. PubMed ID: 28357724
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19).
Puntmann VO; Carerj ML; Wieters I; Fahim M; Arendt C; Hoffmann J; Shchendrygina A; Escher F; Vasa-Nicotera M; Zeiher AM; Vehreschild M; Nagel E
JAMA Cardiol; 2020 Nov; 5(11):1265-1273. PubMed ID: 32730619
[TBL] [Abstract][Full Text] [Related]
14. Proposed Stages of Myocardial Phenotype Development in Fabry Disease.
Nordin S; Kozor R; Medina-Menacho K; Abdel-Gadir A; Baig S; Sado DM; Lobascio I; Murphy E; Lachmann RH; Mehta A; Edwards NC; Ramaswami U; Steeds RP; Hughes D; Moon JC
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1673-1683. PubMed ID: 29778854
[TBL] [Abstract][Full Text] [Related]
15. Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study.
Rutherford E; Mangion K; McComb C; Bell E; Cockburn S; Talle M; Roditi G; Welsh P; Woodward R; Radjenovic A; Struthers AD; Jardine AG; Berry C; Patel RK; Mark PB
Sci Rep; 2017 Oct; 7(1):13976. PubMed ID: 29070834
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular magnetic resonance myocardial T1 mapping to detect and quantify cardiac involvement in familial amyloid polyneuropathy.
Oda S; Utsunomiya D; Morita K; Nakaura T; Yuki H; Kidoh M; Hirata K; Taguchi N; Tsuda N; Shiraishi S; Namimoto T; Hirakawa K; Takashio S; Izumiya Y; Yamamuro M; Hokimoto S; Tsujita K; Ueda M; Yamashita T; Ando Y; Yamashita Y
Eur Radiol; 2017 Nov; 27(11):4631-4638. PubMed ID: 28477167
[TBL] [Abstract][Full Text] [Related]
17. Early effects of kidney transplantation on the heart - A cardiac magnetic resonance multi-parametric study.
Hayer MK; Radhakrishnan A; Price AM; Baig S; Liu B; Ferro CJ; Captur G; Townend JN; Moon JC; Edwards NC; Steeds RP
Int J Cardiol; 2019 Oct; 293():272-277. PubMed ID: 31272740
[TBL] [Abstract][Full Text] [Related]
18. Value of native T1 mapping in the prediction of major adverse cardiovascular events in hemodialysis patients.
Qin L; Gu S; Xiao R; Liu P; Yan F; Yu H; Yang W
Eur Radiol; 2022 Oct; 32(10):6878-6890. PubMed ID: 35554644
[TBL] [Abstract][Full Text] [Related]
19. Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T₁ mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study.
Ng AC; Auger D; Delgado V; van Elderen SG; Bertini M; Siebelink HM; van der Geest RJ; Bonetti C; van der Velde ET; de Roos A; Smit JW; Leung DY; Bax JJ; Lamb HJ
Circ Cardiovasc Imaging; 2012 Jan; 5(1):51-9. PubMed ID: 22135399
[TBL] [Abstract][Full Text] [Related]
20. Association of Elevated NT-proBNP With Myocardial Fibrosis in the Multi-Ethnic Study of Atherosclerosis (MESA).
Liu CY; Heckbert SR; Lai S; Ambale-Venkatesh B; Ostovaneh MR; McClelland RL; Lima JAC; Bluemke DA
J Am Coll Cardiol; 2017 Dec; 70(25):3102-3109. PubMed ID: 29268924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
